BRIJ Medical upsizes raise to $5M as board leads surgical device push
What's the deal? BRIJ Medical, a San Diego medical technology company focused on surgical incision management, has closed a $5 million early-stage financing round. The round was led by the company's board of directors, with most participation coming from existing investors.
Why now? BRIJ initially set out to raise $3 million but upsized the round to $5 million in response to investor demand. The raise follows the July 2026 launch of BRIJ-SEAL, the company's wound closure device, and comes as BRIJ prepares to introduce BRIJ-Ag, a silver-based antimicrobial wound dressing, later this quarter.
What's the endgame? Proceeds will fund commercial expansion and the upcoming product launch. BRIJ's portfolio — which also includes Brijjit, a tension offloading device — is now used by surgeons across orthopedic, plastic, and spine procedures in the US and Canada.
What they're saying: "We set out to raise $3 million and chose to upsize the round because our investors saw the same opportunity we do," said chief executive officer Tim Gleeson. Board chairman John Grotting added that the company is "at an important inflection point."
The signal: At $5 million, the round sits in the lower tier of venture financings — a modest but telling vote of confidence from insiders. A board-led, existing-investor round that outpaces its own target suggests BRIJ is converting early commercial traction into capital, rather than chasing new backers to prove its case.
Read more: prnewswire.com
Image credit: BRIJ Medical
